Corentec Co

Corentec Co EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Corentec Co (104540.KQ) as of Oct 17, 2026 is 5.41 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 1.49 % — a change of 263.49% (higher).

EBIT/Assets

5.41 %

YoY

263.49%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Corentec Co is 2025 5.41 % . Operating Income to Assets Ratio (EBIT/Assets) of Corentec Co was 2024 1.49 % . It decreases by 263.49% higher compared to the previous year.

The Corentec Co EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
-43.97 KRW
Jan 1, 2019
3.73 KRW
Jan 1, 2020
3.46 KRW
Jan 1, 2021
2.35 KRW
Jan 1, 2022
4.36 KRW
Jan 1, 2023
5.55 KRW
Jan 1, 2024
1.49 KRW
Jan 1, 2025
5.41 KRW
The Corentec Co EBIT/Assets history
YEAREBIT/AssetsYoY
5.41 %+263.49%
1.49 %-73.20%
5.55 %+27.25%
4.36 %+85.99%
2.35 %-32.11%
3.46 %-7.37%
3.73 %-108.49%
-43.97 %+501.77%
-7.31 %-1,718.93%
0.45 %-66.81%
1.36 %-583.25%
-0.28 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co Ltd is a South Korean company headquartered in Cheonan, operating within the Health Care sector. The company went public on March 5, 2013, as indicated by its IPO date. Corentec specializes in the manufacture and sale of artificial articulations, focusing on orthopedic products. Its product portfolio includes hip systems such as primary systems, hemi-arthroplasty systems, and revision systems, featuring cementless and cemented femoral stems, acetabular cups, and bearing systems. The company also offers knee products, comprising primary fixed and mobile type systems, revision knee systems, and augment systems. Additionally, Corentec provides spine products, including pedicle screws and peek cages. The firm markets its hip products under the BENCOX brand, while knee and spine products are sold under the LOSPA and LOSPA IS brand names, respectively. Corentec serves both domestic and international markets, distributing its products globally. The company's website is www.corentec.com. Corentec's business model centers on developing and commercializing orthopedic solutions for joint replacement and spinal care, with a focus on quality and innovation in medical devices. The company's operations are based in Cheonan, South Korea, and it has maintained a presence in the health care industry since its IPO in 2013. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Operating Income to Assets Ratio (EBIT/Assets) of Corentec Co is 5.41 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Corentec Co changed from 1.49 % to 5.41 %, representing a 263.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Corentec Co since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Corentec Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Corentec Co

All Key Metrics — Corentec Co